Home/Filings/4/A/0001179110-11-003838
4/A//SEC Filing

EYLENBOSCH HILDE 4/A

Accession 0001179110-11-003838

CIK 0001145460other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 9:25 PM ET

Size

9.7 KB

Accession

0001179110-11-003838

Insider Transaction Report

Form 4/AAmended
Period: 2011-01-19
EYLENBOSCH HILDE
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2011-01-191,2000 total
    Exercise: $14.92From: 2001-11-21Exp: 2011-02-12Common Stock (1,200 underlying)
  • Exercise/Conversion

    Common Stock

    2011-01-19$14.92/sh+1,200$17,9042,800 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    39,143
  • Common Stock

    3,248
Footnotes (5)
  • [F1]This option was acquired through a restructuring transaction undertaken by the Issuer's former parent, Inverness Medical Technology, Inc. in connection with the consummation of the transactions contemplated by the agreement and plan of split-off and merger dated as of May 23, 2001 among Johnson & Johnson, Sunrise Acquisition Corp. and Inverness Medical Technology, Inc.
  • [F2]This derivative security does not have a price.
  • [F3]The reporting person disclaims beneficial ownership of the reported securities.
  • [F4]This form has been amended (a) to correct an error in the aggregate number of shares directly owned by the reporting person following the transaction, (b) to include shares jointly owned by the reporting person which were unintentionally omitted, and (c) correct the aggregate number of shares owned by the spouse of the reporting person for shares acquired through cash exercises of stock options in 2005 and 2008 that were not previously reported.
  • [F5]These securities are jointly owned with the reporting person's spouse.

Documents

1 file

Issuer

ALERE INC.

CIK 0001145460

Entity typeother

Related Parties

1
  • filerCIK 0001272540

Filing Metadata

Form type
4/A
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:25 PM ET
Size
9.7 KB